Pradžia › Plaučių vėžys › Texas › Dallas
Plaučių vėžys klinikiniai tyrimai Dallas, TX
27 tyrimai dėl Plaučių vėžys ieško dalyvių vietose Dallas ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Renkami dalyviai3 fazė
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Renkami dalyviai1/2 fazė
- UT Southwest Simmons Cancer Center, Dallas
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Renkami dalyviai2 fazė
- Texas Oncology - DFW ( Site 8003), Dallas
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Renkami dalyviai3 fazė
- Parkland Memorial Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Renkami dalyviai3 fazė
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Renkami dalyviai1 fazė
- SCRI at Mary Crowley, Dallas
- University of Texas Southwestern Medical Center, Dallas
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Renkami dalyviai3 fazė
- Texas Oncology Dallas, Dallas
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Renkami dalyviai3 fazė
- Texas Oncology - DFW, Dallas
- Texas Oncology - DFW, Dallas
- Texas Oncology - DFW, Dallas
- ir dar 2
A Registry for People With Lung Cancer
Renkami dalyviaiStebimasis tyrimas
- Baylor University Medical Center (Data Collection Only), Dallas
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Renkami dalyviai2/3 fazė
- Local Institution - 0433, Dallas
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Renkami dalyviai1 fazė
- NEXT - Dallas, Dallas
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Renkami dalyviai3 fazė
- The University of Texas Southwestern Medical Center at Dallas, Dallas
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Renkami dalyviai1/2 fazė
- Avenzo Therapeutics Recruiting Site, Dallas
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Renkami dalyviai3 fazė
- Texas Oncology, Dallas
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
Renkami dalyviaiAnkstyvoji 1 fazė
- University of Texas Southwestern Medical Center, Dallas
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Renkami dalyviai1 fazė
- Sarah Cannon Research Institute at Mary Crowley, Dallas
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Renkami dalyviai1/2 fazė
- UT Southwestern Medical Center, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Renkami dalyviai1/2 fazė
- Mary Crowley Cancer Research, Dallas
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Renkami dalyviai2 fazė
- UT Southwestern Medical Center, Dallas
Metabolic Biomarkers in Thoracic Cancers
Renkami dalyviai
- University of Texas Southwestern Medical Center, Dallas
Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer
Renkami dalyviaiStebimasis tyrimas
- UT Southwestern Medical Center, Dallas
Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer
Renkami dalyviai2 fazė
- University of Texas Southwestern Medical Center, Dallas
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Renkami dalyviai1 fazė
- NEXT Dallas, Dallas
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Renkami dalyviai1 fazė
- Mary Crowley Cancer Research, Dallas
- Baylor University Medical Center, Dallas
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Renkami dalyviai1/2 fazė
- NEXT Oncology Dallas, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Renkami dalyviaiStebimasis tyrimas
- Massive Bio SYNERGY-AI site, Dallas
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Renkami dalyviai1/2 fazė
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
Plaučių vėžys tyrimai kituose miestuose
- Houston, TX78 tyrimai
- Boston, MA62 tyrimai
- New York City, NY60 tyrimai
- Los Angeles, CA45 tyrimai
- Washington, DC41 tyrimas
- Arlington, VA41 tyrimas
- Chicago, IL41 tyrimas
- Nashville, TN40 tyrimai
- Baltimore, MD40 tyrimai
- St. Louis, MO39 tyrimai
- Columbus, OH37 tyrimai
- Philadelphia, PA36 tyrimai
Kiti tyrimai Dallas
- Krūties vėžys55 tyrimai
- Nedidelinių ląstelių plaučių vėžys52 tyrimai
- Metastatinis vėžys42 tyrimai
- Širdies nepakankamumas42 tyrimai
- Vėžys (visų tipų)37 tyrimai
- Prostatos vėžys36 tyrimai
- Storosios ir tiesiosios žarnos vėžys33 tyrimai
- Nutukimas30 tyrimai
- Kiaušidžių vėžys28 tyrimai
- Šlapimo pūslės vėžys27 tyrimai
- Endometrio vėžys24 tyrimai
- Širdies ir kraujagyslių ligos23 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.